An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

Joey Gonzalez, global co-CEO of Barry’s, joins CNBC to discuss outlooks on fitness in the era of GLP-1 drugs, trends in gym ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Jessica Alba shared new family pics with husband Cash Warren days after sparking rumors of marital strife. Jessica Klepser, ...

Seeking Alpha analyst Terry Chrisomalis regards Viking Therapeutics as the most attractive M&A candidate in 2025, bolstered ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Enjoy unlimited access to all of our incredible journalism, in print and digital.

For the first time in a decade, body mass index and obesity prevalence in adults declined in the United States in 2023.